Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 275 of 349 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/17/20
End: 11/30/24
Due: 11/30/25
Phase: N/A
Priority: Normal
Start: 04/30/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/15/15
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 03/31/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/03
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 08/31/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/01
End: -
Due: -
Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
Phase: N/A
Priority: Normal
Start: 01/31/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/95
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 03/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 11/30/22
Due: 11/30/23
Phase: N/A
Priority: Normal
Start: 05/03/17
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 03/31/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/02
End: 11/30/05
Due: 11/30/06
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 01/31/21
Due: 01/31/22
Phase: N/A
Priority: Normal
Start: 05/31/07
End: 03/31/09
Due: 03/31/10
Phase: N/A
Priority: Normal
Start: 04/30/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/20
End: 10/31/27
Due: 10/31/28
Phase: N/A
Priority: Normal
Start: 04/30/01
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 09/30/13
End: 03/10/20
Due: 03/10/21
Phase: N/A
Priority: Normal
Start: 09/30/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 05/31/17
Due: 05/31/18
Phase: N/A
Priority: Normal
Start: 01/31/07
End: -
Due: -